MedTrace Logo

Examining Risk Factors for Atypical Antipsychotic Metabolic Side Effects

NCT00815854 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2019-06-21

No results posted yet for this study

Summary

This study will examine possible causes of metabolic side effects in people taking atypical antipsychotic (AAP) medications.

Conditions

Interventions

DIETARY_SUPPLEMENT

Folic Acid

5 mg of folic acid taken daily for 3 months in an open label fashion

OTHER

Placebo

Subjects may receive placebo (a sugar pill) for 4 months

Sponsors & Collaborators

Principal Investigators

  • Vicki L. Ellingrod, PharmD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00815854 on ClinicalTrials.gov